drugset
Drugs / D745
last change Nov 2025 re-read 2 minutes ago

D745

Developed for
type 2 diabetes mellitus
Investigated by
Chong Kun Dang Pharmaceutical

Trials 12 · a red edge is where a trial was stopped

today NCT07304726 · Ph 1 NCT07304687 · Ph 1 NCT05897216 · Ph 1 NCT05928637 · Ph 1 NCT05952219 · Ph 1 NCT05741437 · Ph 1 NCT05719155 · Ph 1 NCT05566028 · Ph 3 NCT05452525 · Ph 1 NCT04810676 · Ph 1 NCT04334213 · Ph 1 NCT03849495 · Ph 1
20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 111 trials
Phase 1 NCT07304726 Oct → Nov 2025 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT07304687 Oct → Nov 2025 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05897216 Jul 2023 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05928637 Jul → Aug 2023 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05952219 Jun 2023 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Unknown No outcome recorded
Phase 1 NCT05741437 Apr → Aug 2023 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05719155 Feb → Mar 2023 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05452525 Jul → Aug 2022 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT04810676 Apr → May 2021 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT04334213 May → Aug 2020 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 31 trial
Phase 3 NCT05566028 Oct 2022 → Jan 2024 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 12 sources stand behind the page.

FieldValueCited text
Known as D745 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05741437 ↗
11

NCT05719155 ↗

NCT05952219 ↗

NCT04810676 ↗

NCT03849495 ↗

NCT07304687 ↗

NCT05566028 ↗

NCT05897216 ↗

NCT05928637 ↗

NCT04334213 ↗

NCT05452525 ↗

NCT07304726 ↗
Route Oral “oral administration of D745, D150 and CKD-501” NCT04334213 ↗